SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011141
Filing Date
2021-08-10
Accepted
2021-08-10 16:18:59
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20210630x10q.htm   iXBRL 10-Q 1957694
2 EX-31.1 olma-20210630xex31d1.htm EX-31.1 12660
3 EX-31.2 olma-20210630xex31d2.htm EX-31.2 12696
4 EX-32 olma-20210630xex32.htm EX-32 10401
  Complete submission text file 0001558370-21-011141.txt   6441785

Data Files

Seq Description Document Type Size
5 EX-101.SCH olma-20210630.xsd EX-101.SCH 38365
6 EX-101.CAL olma-20210630_cal.xml EX-101.CAL 43717
7 EX-101.DEF olma-20210630_def.xml EX-101.DEF 118430
8 EX-101.LAB olma-20210630_lab.xml EX-101.LAB 409509
9 EX-101.PRE olma-20210630_pre.xml EX-101.PRE 289248
10 EXTRACTED XBRL INSTANCE DOCUMENT olma-20210630x10q_htm.xml XML 967413
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 211160179
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences